SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-09
DOI
10.3389/fonc.2019.01035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers
- (2019) Daniel Hui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression
- (2019) Shira Toledano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
- (2019) Ze Zhang et al. Frontiers in Oncology
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1
- (2018) James W Peacock et al. EMBO Molecular Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Silencing of semaphorin 3C suppresses cell proliferation and migration in MCF‑7 breast cancer cells
- (2017) Xiaofang Zhu et al. Oncology Letters
- Saving the World’s Women from Cervical Cancer
- (2016) Vivien Tsu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner
- (2016) Kevin J Tam et al. Oncotarget
- Perineural invasion as a prognostic factor for cervical cancer: a systematic review and meta-analysis
- (2015) Ling Cui et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis
- (2015) Yelena Mumblat et al. CANCER RESEARCH
- Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis
- (2015) W.-J. Yang et al. EMBO Molecular Medicine
- Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism
- (2015) Zheng Hu et al. NATURE GENETICS
- The Role of Signaling Pathways in Cervical Cancer and Molecular Therapeutic Targets
- (2014) Joaquín Manzo-Merino et al. ARCHIVES OF MEDICAL RESEARCH
- The potential of class 3 semaphorins as both targets and therapeutics in cancer
- (2014) Rosalin Mishra et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
- (2014) Jianghong Man et al. Cell Reports
- Resistance to BRAF-targeted therapy in melanoma
- (2013) Ryan J. Sullivan et al. EUROPEAN JOURNAL OF CANCER
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer
- (2012) Luca Tamagnone CANCER CELL
- Semaphorin 3C is involved in the progression of gastric cancer
- (2012) Hideyo Miyato et al. CANCER SCIENCE
- Semaphorins in cancer: Biological mechanisms and therapeutic approaches
- (2012) Michael Rehman et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
- (2011) Mohammad H Forouzanfar et al. LANCET
- Perineural invasion in cancer
- (2009) Catherine Liebig et al. CANCER
- The Cleavage of Semaphorin 3C Induced by ADAMTS1 Promotes Cell Migration
- (2009) Cary Esselens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now